Alembic Ltd
Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.
With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.[1]
- Market Cap ₹ 3,210 Cr.
- Current Price ₹ 125
- High / Low ₹ 169 / 78.1
- Stock P/E 25.6
- Book Value ₹ 33.0
- Dividend Yield 1.92 %
- ROCE 12.4 %
- ROE 11.2 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 18.1% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 63.8%
- Debtor days have improved from 60.2 to 41.7 days.
- Company's working capital requirements have reduced from 146 days to 79.2 days
Cons
- Stock is trading at 3.73 times its book value
- Tax rate seems low
- Company has a low return on equity of 9.84% over last 3 years.
- Earnings include an other income of Rs.71.6 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Realty Industry: Construction
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
179 | 154 | 144 | 134 | 147 | 125 | 124 | 74 | 72 | 76 | 123 | 152 | 186 | |
164 | 126 | 134 | 128 | 140 | 114 | 106 | 70 | 62 | 63 | 85 | 96 | 111 | |
Operating Profit | 16 | 28 | 10 | 6 | 7 | 11 | 18 | 4 | 11 | 13 | 38 | 56 | 74 |
OPM % | 9% | 18% | 7% | 5% | 5% | 9% | 15% | 5% | 15% | 17% | 31% | 37% | 40% |
10 | 18 | 21 | 25 | 25 | 37 | 29 | 93 | 10 | 89 | 54 | 55 | 72 | |
Interest | 5 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Depreciation | 10 | 8 | 6 | 6 | 5 | 4 | 3 | 3 | 4 | 4 | 6 | 7 | 9 |
Profit before tax | 11 | 33 | 23 | 25 | 27 | 44 | 45 | 94 | 17 | 97 | 85 | 103 | 136 |
Tax % | -4% | 12% | -3% | 2% | -3% | 5% | 8% | 0% | 19% | 12% | 7% | 10% | |
11 | 30 | 24 | 25 | 27 | 42 | 41 | 94 | 13 | 86 | 79 | 93 | 125 | |
EPS in Rs | 0.43 | 1.11 | 0.90 | 0.93 | 1.03 | 1.56 | 1.60 | 3.64 | 0.52 | 3.34 | 3.09 | 3.62 | 4.89 |
Dividend Payout % | 23% | 14% | 17% | 16% | 19% | 13% | 12% | 16% | 38% | 54% | 71% | 66% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 4% |
3 Years: | 28% |
TTM: | 40% |
Compounded Profit Growth | |
---|---|
10 Years: | 12% |
5 Years: | 18% |
3 Years: | 112% |
TTM: | 45% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 19% |
3 Years: | 8% |
1 Year: | 49% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 10% |
3 Years: | 10% |
Last Year: | 11% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 27 | 53 | 53 | 53 | 53 | 53 | 51 | 51 | 51 | 51 | 51 | 51 | 51 |
Reserves | 179 | 177 | 211 | 295 | 314 | 395 | 361 | 432 | 775 | 962 | 778 | 757 | 797 |
25 | 22 | 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 16 | |
113 | 104 | 91 | 64 | 81 | 73 | 57 | 51 | 109 | 130 | 119 | 128 | 172 | |
Total Liabilities | 344 | 356 | 356 | 421 | 449 | 522 | 470 | 534 | 936 | 1,144 | 948 | 946 | 1,037 |
185 | 178 | 169 | 146 | 171 | 179 | 209 | 225 | 261 | 294 | 318 | 366 | 382 | |
CWIP | 3 | 2 | 2 | 0 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 1 | 0 |
Investments | 23 | 21 | 35 | 150 | 189 | 276 | 205 | 197 | 581 | 726 | 503 | 411 | 453 |
132 | 155 | 149 | 124 | 89 | 67 | 55 | 109 | 88 | 124 | 127 | 168 | 201 | |
Total Assets | 344 | 356 | 356 | 421 | 449 | 522 | 470 | 534 | 936 | 1,144 | 948 | 946 | 1,037 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
80 | -10 | 22 | 10 | 52 | 24 | 22 | 5 | -1 | -22 | 35 | 25 | |
12 | 18 | 5 | -5 | -47 | -23 | 68 | 57 | -35 | 23 | 11 | 23 | |
-94 | -8 | -25 | -5 | -5 | -3 | -89 | -6 | -15 | -6 | -46 | -48 | |
Net Cash Flow | -2 | -0 | 2 | -0 | -0 | -2 | 1 | 56 | -52 | -5 | -0 | 0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 37 | 66 | 122 | 76 | 54 | 74 | 40 | 44 | 66 | 72 | 67 | 42 |
Inventory Days | 351 | 1,924 | 880 | 659 | 438 | 247 | 289 | 411 | 2,112 | 2,885 | 5,118 | 3,694 |
Days Payable | 173 | 659 | 200 | 144 | 128 | 125 | 202 | 151 | 675 | 635 | 993 | 1,213 |
Cash Conversion Cycle | 215 | 1,330 | 801 | 591 | 364 | 195 | 126 | 304 | 1,504 | 2,322 | 4,191 | 2,523 |
Working Capital Days | 93 | 200 | 235 | 172 | 39 | 20 | 13 | 28 | 98 | 231 | 127 | 79 |
ROCE % | 6% | 16% | 9% | 8% | 8% | 10% | 10% | 21% | 2% | 10% | 10% | 12% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 15 Nov
-
Intimation Under Regulation 30 Of SEBI (LODR), Regulation 2015
13 Nov - Company received warning letter from NSE regarding PAN disclosure.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
9 Nov - Paper cuttings of Extract of Unaudited Financial Results of the Company for the Quarter and Half year ended 30th September, 2024 published in Indian Express …
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
9 Nov - Intimation of loss of share certificate and request for duplicate.
-
Unaudited Financial Financial Results For The Quarter And Half Year Ended 30Th September, 2024.
8 Nov - Board approved unaudited financial results for Q2 FY2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
Business Segments
A) Real Estate (~80% in FY24 vs 59% in FY22): [1] [2] The company is involved in the construction of residential & commercial real estate projects. It also leases commercial properties. [3] Real Estate business experienced strong growth between FY23-FY24 bolstered by strong demand and higher property prices. [4]